OH HB 682
in committeeProhibit certain insurance practices
Ohio · 2025-2026 Regular Session (136th General Assembly) · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did OH HB 682 pass?
Not yet. OH HB 682 is in committee and has not come to a final vote. Latest recorded action (2026-02-18): Referred to committee
What is OH HB 682 about?
To enact section 3902.65 of the Revised Code to prohibit certain insurance practices related to physician-administered drugs for patients with chronic, complex, rare, or life-threatening medical conditions.
Who sponsors OH HB 682?
Gayle Manning, Meredith Craig are the primary sponsors of OH HB 682.
Description
To enact section 3902.65 of the Revised Code to prohibit certain insurance practices related to physician-administered drugs for patients with chronic, complex, rare, or life-threatening medical conditions.
- Introduced
- 2026-02-04
- Latest action
- 2026-02-18 — Referred to committee
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Gayle Manningprimary
- Meredith Craigprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-02-18
Referred to committee
referral-committee
2026-02-04
Introduced
introduction
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:30:02.217700Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=OH&identifier=HB 682. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.